Isoprenoid metabolism and the pleiotropic effects of statins
- 1 September 2003
- journal article
- review article
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 5 (5) , 372-378
- https://doi.org/10.1007/s11883-003-0008-z
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Prevention of stroke and dementia with statins: effects beyond lipid loweringThe American Journal of Cardiology, 2003
- Statin effects beyond lipid lowering—are they clinically relevant?European Heart Journal, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Statins as antioxidant therapy for preventing cardiac myocyte hypertrophyJournal of Clinical Investigation, 2001
- Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.The American Journal of Cardiology, 2001
- Inhibition of proinflammatory cytokine production by pravastatinThe Lancet, 1999
- EVALUATION OF FLUVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA IN RENAL TRANSPLANT RECIPIENTS TAKING CYCLOSPORINE1Transplantation, 1996
- Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductaseThe American Journal of Cardiology, 1994
- Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular DiseaseNew England Journal of Medicine, 1990
- Regulation of the mevalonate pathwayNature, 1990